Lataa...
Neovascular Age‐Related Macular Degeneration: A Visual Acuity Model of Natural Disease Progression and Ranibizumab Treatment Effect
Intravitreal ranibizumab is a first‐line therapy for neovascular age‐related macular degeneration (nAMD), but there is a need to optimize patient outcomes while minimizing treatment burden. Here, we developed an indirect response, nonlinear, mixed effects model of disease progression and drug effect...
Tallennettuna:
| Julkaisussa: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202467/ https://ncbi.nlm.nih.gov/pubmed/30043524 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12322 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|